Development and validation of a bona fide iPSC derived human neuronal infection model to evaluate antivirals targeted against neurotropic viral infections.
Valorization of novel strategies for the prevention of viral infection and inhibition of viral replication.
Productive replication of nephropathogenic infectious bronchitis virus in peripheral blood monocytic cells, a strategy for viral dissemination and kidney infection in chickens
Eradication of persistent bovine viral diarrhea virus infection in cell culture by antiviral treatment: how to get ahead of the viral evasion strategy
Viral metagenomics enables accurate detection of viral pathogens in amniotic fluid samples from pregnant women with suspicion of congenital infection
Dual infection with human immunodeficiency virus type 1 and type 2: impact on HIV type 1 viral load and immune activation markers in HIV-seropositive female sex workers in Abidjan, Ivory Coast
HIV-1 Viral Loads Are Not Elevated in Individuals Co-infected With Schistosoma spp. After Adjustment for Duration of HIV-1 Infection
Novel antiviral compounds, a process for their preparation, and their use for treating viral infections
Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
Replication Data for: Impact of alkoxy chain length and concentration on the chiral induction of self-assembled molecular networks under nanoconfinement conditions